Safety
and Immunogenicity of 3 Doses of BNT162b2 and CoronaVac in Children and
Adults with Inborn Errors of Immunity
Daniel Leung,1,* Xiaofeng Mu,1,*
Jaime S Rosa Duque,1,* Samuel MS
Cheng,2,* Manni Wang,1 Wenyue
Zhang,1 Yanmei Zhang,1 Issan YS
Tam,1 Toby SS Lee,1 Jennifer HY
Lam,1 Sau Man Chan,1 Cheuk Hei
Cheang,1 Yuet Chung,1 Howard HW
Wong,1 Amos MT Lee,1 Wing Yan
Li,1 Sara Chaothai,2 Leo CH
Tsang,2 Gilbert T Chua,1 Kai-Ning
Cheong,3 Elaine YL Au,4 Janette SY
Kwok,5 Koon Wing Chan,1 Patrick CY
Chong,6 Pamela PW Lee,1 Marco HK
Ho,6 Tsz Leung Lee,3 Wenwei
Tu,1,† Malik Peiris,2,7,† Yu Lung
Lau,1,†
1 Department of Paediatrics and Adolescent Medicine,
The University of Hong Kong, Hong Kong, China
2 School of Public Health, The University of Hong
Kong, Hong Kong, China
3 Hong Kong Children’s Hospital, Hong Kong, China
4 Division of Clinical Immunology, Department of
Pathology, Queen Mary Hospital, Hong Kong, China
5 Division of Transplantation and Immunogenetics,
Department of Pathology, Queen Mary Hospital, Hong Kong, China
6 Virtus Medical, Hong Kong, China
7 Centre for Immunology & Infection C2i, Hong Kong,
China
*, denotes co-first authors who contributed equally
†, denotes co-corresponding authors who contributed
equally